Jupiter Investment Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Jupiter Investment Management’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-2,507,002	Closed	-$135M	–	473
2017 Q4	$135M	Buy	2,507,002 +810,364	+48%	+$44.3M	1.25%	28
2017 Q3	$96.8M	Buy	1,696,638 +1,371,016	+421%	+$80.3M	1.01%	33
2017 Q2	$19.6M	Buy	325,622 +281,032	+630%	+$16M	0.24%	105
2017 Q1	$2.43M	Buy	+44,590	New	+$2.2M	0.03%	195

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Jupiter Investment Management's BIVV Position: Q1 2018 in Review

Jupiter Investment Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 2,507,002 shares — an estimated $135M sold.

Jupiter Investment Management first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $135M in Q4 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Jupiter Investment Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Jupiter Investment Management sold 2,507,002 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $135M.
Jupiter Investment Management first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
Jupiter Investment Management's Bioverativ Inc. Common Stock position peaked at $135M in Q4 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Jupiter Investment Management's 13F filing for Q1 2018, filed 14 May 2018.